1. Home
  2. EPR vs RLAY Comparison

EPR vs RLAY Comparison

Compare EPR & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EPR Properties

EPR

EPR Properties

HOLD

Current Price

$62.07

Market Cap

4.6B

Sector

Real Estate

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$19.73

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPR
RLAY
Founded
1997
2015
Country
United States
United States
Employees
54
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EPR
RLAY
Price
$62.07
$19.73
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$58.94
$19.50
AVG Volume (30 Days)
531.8K
4.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
6.28%
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
N/A
$15,355,000.00
Revenue This Year
$2.66
N/A
Revenue Next Year
$8.60
$324.03
P/E Ratio
$25.00
N/A
Revenue Growth
N/A
53.44
52 Week Low
$48.11
$3.03
52 Week High
$62.18
$20.79

Technical Indicators

Market Signals
Indicator
EPR
RLAY
Relative Strength Index (RSI) 68.87 62.76
Support Level $57.44 $12.10
Resistance Level N/A $20.79
Average True Range (ATR) 1.05 1.31
MACD 0.26 -0.09
Stochastic Oscillator 79.41 73.40

Price Performance

Historical Comparison
EPR
RLAY

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: